tradingkey.logo

Cosmos Health Inc

COSM
View Detailed Chart

0.953USD

+0.021+2.30%
Close 09/19, 16:00ETQuotes delayed by 15 min
28.33MMarket Cap
LossP/E TTM

Cosmos Health Inc

0.953

+0.021+2.30%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.30%

5 Days

+1.90%

1 Month

+14.86%

6 Months

+91.58%

Year to Date

+42.50%

1 Year

-12.54%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a . Despite a very weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
120 / 175
Overall Ranking
454 / 4720
Industry
Pharmaceuticals

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
3.000
Target Price
+511.87%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.
Growing
The company is in a growing phase, with the latest annual income totaling USD 54.43M.
Undervalued
The company’s latest PE is -0.92, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 11.57M shares, increasing 18.35% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 134.83K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.15.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.
Ticker SymbolCOSM
CompanyCosmos Health Inc
CEOMr. Grigorios Siokas
Websitehttps://www.cosmosholdingsinc.com/
KeyAI